Atrial Fibrillation and Human Immunodeficiency Virus Type-1 Infection: A Systematic Review. Implications for Anticoagulant and Antiarrhythmic Therapy.

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.13837
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2016English

Managing Atrial Fibrillation: Catheter Ablation or Antiarrhythmic Therapy?

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2009English

The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2015English

Virus Population Homogenization Following Acute Human Immunodeficiency Virus Type 1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2002English

Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection Through Virus Binding

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Decelerating Decay of Latently Infected Cells During Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2002English

Combined Aspirin and Anticoagulant Therapy in Patients With Atrial Fibrillation

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy